72 related articles for article (PubMed ID: 29751395)
1. The overarching framework of translation and integration into healthcare: a case for the LAL model.
Lal JA; Morré SA; Brand A
Per Med; 2014 Jan; 11(1):41-62. PubMed ID: 29751395
[TBL] [Abstract][Full Text] [Related]
2. The Learning-Adapting-Leveling model: from theory to hypothesis of steps for implementation of basic genome-based evidence in personalized medicine.
Lal JA; Vaidya A; Gutiérrez-Ibarluzea I; Dauben HP; Brand A
Per Med; 2013 Sep; 10(7):683-701. PubMed ID: 29768763
[TBL] [Abstract][Full Text] [Related]
3. Public health and valorization of genome-based technologies: a new model.
Lal JA; Schulte In den Bäumen T; Morré SA; Brand A
J Transl Med; 2011 Dec; 9():207. PubMed ID: 22142533
[TBL] [Abstract][Full Text] [Related]
4. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
5. The contribution of health technology assessment, health needs assessment, and health impact assessment to the assessment and translation of technologies in the field of public health genomics.
Rosenkötter N; Vondeling H; Blancquaert I; Mekel OC; Kristensen FB; Brand A
Public Health Genomics; 2011; 14(1):43-52. PubMed ID: 20926845
[TBL] [Abstract][Full Text] [Related]
6. Concepts for the translation of genome-based innovations into public health: a comprehensive overview.
Syurina EV; Schulte In den Bäumen T; Brand A; Ambrosino E; Feron FJ
Per Med; 2013 Mar; 10(2):163-176. PubMed ID: 29758851
[TBL] [Abstract][Full Text] [Related]
7. Working towards personalization in medicine: main obstacles to reaching this vision from today's perspective.
Leyens L; Horgan D; Lal JA; Steinhausen K; Satyamoorthy K; Brand A
Per Med; 2014 Sep; 11(7):641-649. PubMed ID: 29764055
[TBL] [Abstract][Full Text] [Related]
8. Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.
Siebert U; Jahn B; Rochau U; Schnell-Inderst P; Kisser A; Hunger T; Sroczynski G; Mühlberger N; Willenbacher W; Schnaiter S; Endel G; Huber L; Gastl G;
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):330-40. PubMed ID: 26354133
[TBL] [Abstract][Full Text] [Related]
9. H2020 EU Research & Innovation Program Boost the Transfer of Technological Breakthroughs, Enable New Solutions for Personalised Health and Impact the Industry and Healthcare Systems.
Smit PH; Lymberis A
Stud Health Technol Inform; 2015; 211():3-17. PubMed ID: 25980846
[TBL] [Abstract][Full Text] [Related]
10. Chlamydia trachomatis infections and subfertility: opportunities to translate host pathogen genomic data into public health.
Lal JA; Malogajski J; Verweij SP; de Boer P; Ambrosino E; Brand A; Ouburg S; Morré SA
Public Health Genomics; 2013; 16(1-2):50-61. PubMed ID: 23548718
[TBL] [Abstract][Full Text] [Related]
11. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
12. Adapting a geographical information system-based water resource management to the needs of the Romanian water authorities.
Soutter M; Alexandrescu M; Schenk C; Drobot R
Environ Sci Pollut Res Int; 2009 Aug; 16 Suppl 1():S33-41. PubMed ID: 18998185
[TBL] [Abstract][Full Text] [Related]
13. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
14. Stakeholder consultation insights on the future of genomics at the clinical-public health interface.
Modell SM; Kardia SL; Citrin T
Transl Res; 2014 May; 163(5):466-77. PubMed ID: 24434657
[TBL] [Abstract][Full Text] [Related]
15. Smart systems and personalized health: the real challenge of bridging the innovation gap.
Lymberis A
Stud Health Technol Inform; 2014; 200():3-7. PubMed ID: 24851956
[TBL] [Abstract][Full Text] [Related]
16. [How can the impact of Health Technology Assessment (HTA) in the Austrian healthcare system be assessed? Design of a conceptual framework].
Schumacher I; Zechmeister I
Gesundheitswesen; 2012 Apr; 74(4):257-65. PubMed ID: 21267815
[TBL] [Abstract][Full Text] [Related]
17. Steps toward improving ethical evaluation in health technology assessment: a proposed framework.
Assasi N; Tarride JE; O'Reilly D; Schwartz L
BMC Med Ethics; 2016 Jun; 17(1):34. PubMed ID: 27267369
[TBL] [Abstract][Full Text] [Related]
18. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
[TBL] [Abstract][Full Text] [Related]
19. Interactive Two-Way mHealth Interventions for Improving Medication Adherence: An Evaluation Using The Behaviour Change Wheel Framework.
Chiang N; Guo M; Amico KR; Atkins L; Lester RT
JMIR Mhealth Uhealth; 2018 Apr; 6(4):e87. PubMed ID: 29650504
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based management of ambulatory electronic health record system implementation: an assessment of conceptual support and qualitative evidence.
McAlearney AS; Hefner JL; Sieck C; Rizer M; Huerta TR
Int J Med Inform; 2014 Jul; 83(7):484-94. PubMed ID: 24862893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
